Cargando…

Health-Related Quality of Life in Multiple Myeloma Patients Treated with High- or Low-Dose Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation—Results from the LenaMain Trial (NCT00891384)

SIMPLE SUMMARY: High-dose therapy with melphalan followed by autologous stem cell transplantation and lenalidomide maintenance has long been the standard of care for newly diagnosed patients with multiple myeloma. However, it is unclear how lenalidomide dosage or experienced side effects govern pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boquoi, Amelie, Giagounidis, Aristoteles, Goldschmidt, Hartmut, Heinsch, Michael, Rummel, Mathias J., Kröger, Nicolaus, Mai, Elias K., Strapatsas, Judith, Haas, Rainer, Kobbe, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650513/ https://www.ncbi.nlm.nih.gov/pubmed/37958331 http://dx.doi.org/10.3390/cancers15215157

Ejemplares similares

Lenalidomide in the context of complex karyotype or interrupted treatment: case reviews of del(5q)MDS patients with unexpected responses
por: Giagounidis, Aristoteles A. N., et al.
Publicado: (2006)

Lenalidomide (LENA) Hybrid Gold Complex Nanoparticles: Synthesis, Physicochemical Evaluation, and Perspectives in Nanomedicine
por: Arib, Celia, et al.
Publicado: (2020)

Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectations
por: Boquoi, Amelie, et al.
Publicado: (2022)

Lenalidomide: a brief review of its therapeutic potential in myelodysplastic syndromes
por: Giagounidis, Aristoteles A N, et al.
Publicado: (2007)

Therapy-related myeloid neoplasms following treatment for multiple myeloma—a single center analysis
por: Boquoi, A., et al.
Publicado: (2022)

Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes
por: Giagounidis, Aristoteles, et al.
Publicado: (2008)

Rajando la leña está
por: Vitier, Cintio, 1921-
Publicado: (1986)

Estufas eficientes de leña /
Publicado: (2013)

Mutter Lenas Junge : und andere Erzählungen
por: Geijerstam, Gustaf af, 1858-1909
Publicado: (1892)

Humo de leña : los panaderos de Veracruz
por: Casarín, Susana
Publicado: (2002)

La leña : principal recurso energético en las comunidades rurales. Metodologías para la estimación del consumo doméstico y producción de leña a partir de árboles nativos /
por: Holz, Silvia
Publicado: (2011)

LENA - Low Energy Neutrino Astronomy
por: Hagner, Caren
Publicado: (2012)

Miss Lena Ashwell's Concert Parties
Publicado: (1915)

First person – Lena Marie Westermann
Publicado: (2020)

Lena Ho: Micropeptides under the spotlight
por: Morgado-Palacin, Lucia
Publicado: (2022)

Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes
por: Giagounidis, Aristoteles, et al.
Publicado: (2013)

Seasonal nitrogen fluxes of the Lena River Delta
por: Sanders, Tina, et al.
Publicado: (2021)

Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma
por: Baertsch, Marc-Andrea, et al.
Publicado: (2021)

La leña : el energético rural en tres micro-regiones del sureste de México : una experiencia interactiva con la población local /
Publicado: (2002)

Review of "Medical Image Analysis Methods" by Lena Costaridou
por: Toro, Javier
Publicado: (2006)

The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q)
por: Sekeres, Mikkael A., et al.
Publicado: (2018)

Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial
por: Schroeder, Thomas, et al.
Publicado: (2023)

Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
por: Baertsch, Marc-Andrea, et al.
Publicado: (2021)

Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients
por: Santini, Valeria, et al.
Publicado: (2020)

Use of the LENA Autism Screen with Children who are Deaf or Hard of Hearing
por: VanDam, Mark, et al.
Publicado: (2019)

BALB.NCT-Cpox(nct) is a unique mouse model of hereditary coproporphyria
por: Kang, Xiaojing, et al.
Publicado: (2023)

Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma
por: Baertsch, Marc-Andrea, et al.
Publicado: (2016)

Abastecimiento de leña en la industria rural de Panama : problemas y alternativas forestales /
por: Reiche, Carlos E.
Publicado: (1989)

Lenalidomide before and after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
por: Tuchman, S. A., et al.
Publicado: (2012)

A complete, unabridged, “pre-registered” descriptive experience sampling investigation: The case of Lena
por: Krumm, Alek E., et al.
Publicado: (2021)

Lenalidomide overcomes the immunosuppression of regulatory CD8(+)CD28(−) T-cells
por: Neuber, Brigitte, et al.
Publicado: (2017)

Replication characteristics of porcine reproductive and respiratory syndrome virus (PRRSV) European subtype 1 (Lelystad) and subtype 3 (Lena) strains in nasal mucosa and cells of the monocytic lineage: indications for the use of new receptors of PRRSV (Lena)
por: Frydas, Ilias S, et al.
Publicado: (2013)

Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma
por: Sidiqi, M. Hasib, et al.
Publicado: (2018)

Novel methodology to examine cognitive and experiential factors in language development: combining eye-tracking and LENA technology
por: Odean, Rosalie, et al.
Publicado: (2015)

Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q)
por: Fenaux, Pierre, et al.
Publicado: (2017)

MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma
por: Stroh, Jacob, et al.
Publicado: (2022)

Functional Imaging with (18)F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient
por: Sachpekidis, Christos, et al.
Publicado: (2017)

What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?
por: Zhao, Hao, et al.
Publicado: (2019)

Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better
por: Mohty, Mohamad, et al.
Publicado: (2020)

Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial
por: Puig, Noemi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_laq8cma8qep2vau29gevbm0s5v